Topic
Genmab
BBN has covered 6 stories about Genmab, mostly in U.S. and World, as reported by Investing.com, Bloomberg.com, AP News, WSJ and others. Newest first.
- World
European Shares Rise as Yields and Oil Retreat
Reported by Investing.com - Your Money
Senegal Swaps, U.S. Growth at 2.2%, Genmab Climbs
Reported by Bloomberg.com, AP News, WSJ - World
Europe Climbs as Genmab Jumps and Bond Yields Retreat
Reported by Reuters - Tech
AI Chips Surge, AbbVie Cancer Combo, Cowbell Mystery
Reported by Bloomberg.com, Reuters - U.S.
Genmab, AbbVie Lymphoma Data Lifts Epkinly Outlook
Reported by Seeking Alpha - U.S.
Genmab, AbbVie Lymphoma Drug Hits Phase 3 Goal
Reported by GlobeNewswire Inc.
Related topics
All topics →BBN is a parody news network: the headlines are real and credited to the outlets that reported them; the anchors are fictional and their lines are written by AI. How BBN works.